These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

764 related items for PubMed ID: 17663527

  • 1. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
    Kunstler JU, Veerendra B, Figueroa SD, Sieckman GL, Rold TL, Hoffman TJ, Smith CJ, Pietzsch HJ.
    Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
    [Abstract] [Full Text] [Related]

  • 2. Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3.
    Smith CJ, Sieckman GL, Owen NK, Hayes DL, Mazuru DG, Kannan R, Volkert WA, Hoffman TJ.
    Cancer Res; 2003 Jul 15; 63(14):4082-8. PubMed ID: 12874010
    [Abstract] [Full Text] [Related]

  • 3. Impact of functionalized coligands on the pharmacokinetics of 99mTcIII '4+1' mixed-ligand complexes conjugated to bombesin.
    Kunstler JU, Bergmann R, Gniazdowska E, Koźmiński P, Walther M, Pietzsch HJ.
    J Inorg Biochem; 2011 Nov 15; 105(11):1383-90. PubMed ID: 21946438
    [Abstract] [Full Text] [Related]

  • 4. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
    Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ.
    Nucl Med Biol; 2008 May 15; 35(4):401-11. PubMed ID: 18482677
    [Abstract] [Full Text] [Related]

  • 5. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
    Smith CJ, Sieckman GL, Owen NK, Hayes DL, Mazuru DG, Volkert WA, Hoffman TJ.
    Anticancer Res; 2003 May 15; 23(1A):63-70. PubMed ID: 12680195
    [Abstract] [Full Text] [Related]

  • 6. 99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor.
    Lane SR, Veerendra B, Rold TL, Sieckman GL, Hoffman TJ, Jurisson SS, Smith CJ.
    Nucl Med Biol; 2008 Apr 15; 35(3):263-72. PubMed ID: 18355681
    [Abstract] [Full Text] [Related]

  • 7. Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties.
    Smith CJ, Gali H, Sieckman GL, Higginbotham C, Volkert WA, Hoffman TJ.
    Bioconjug Chem; 2003 Apr 15; 14(1):93-102. PubMed ID: 12526698
    [Abstract] [Full Text] [Related]

  • 8. Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells.
    Smith CJ, Gali H, Sieckman GL, Hayes DL, Owen NK, Mazuru DG, Volkert WA, Hoffman TJ.
    Nucl Med Biol; 2003 Feb 15; 30(2):101-9. PubMed ID: 12623108
    [Abstract] [Full Text] [Related]

  • 9. Efficient preparation of (99m)Tc(III) '4+1' mixed-ligand complexes for peptide labeling with high specific activity.
    Kunstler JU, Seidel G, Pietzsch HJ.
    Appl Radiat Isot; 2010 Sep 15; 68(9):1728-33. PubMed ID: 20430637
    [Abstract] [Full Text] [Related]

  • 10. Novel 99mTc '4 + 1' peptide conjugates: tuning the biodistribution by variation of coligands.
    Kunstler JU, Seidel G, Bergmann R, Gniazdowska E, Walther M, Schiller E, Decristoforo C, Stephan H, Haubner R, Steinbach J, Pietzsch HJ.
    Eur J Med Chem; 2010 Sep 15; 45(9):3645-55. PubMed ID: 20570022
    [Abstract] [Full Text] [Related]

  • 11. The effects of linking substituents on the in vivo behavior of site-directed, peptide-based, diagnostic radiopharmaceuticals.
    Prasanphanich AF, Lane SR, Figueroa SD, Ma L, Rold TL, Sieckman GL, Hoffman TJ, McCrate JM, Smith CJ.
    In Vivo; 2007 Sep 15; 21(1):1-16. PubMed ID: 17354608
    [Abstract] [Full Text] [Related]

  • 12. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
    Nock BA, Cescato R, Ketani E, Waser B, Reubi JC, Maina T.
    J Med Chem; 2012 Oct 11; 55(19):8364-74. PubMed ID: 22966957
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and radiopharmacological evaluation of ⁶⁴Cu-labeled bombesin analogs featuring a bis(2-pyridylmethyl)-1,4,7-triazacyclononane chelator.
    Bergmann R, Ruffani A, Graham B, Spiccia L, Steinbach J, Pietzsch J, Stephan H.
    Eur J Med Chem; 2013 Oct 11; 70():434-46. PubMed ID: 24184988
    [Abstract] [Full Text] [Related]

  • 14. Spacer site modifications for the improvement of the in vitro and in vivo binding properties of (99m)Tc-N(3)S-X-bombesin[2-14] derivatives.
    Fragogeorgi EA, Zikos C, Gourni E, Bouziotis P, Paravatou-Petsotas M, Loudos G, Mitsokapas N, Xanthopoulos S, Mavri-Vavayanni M, Livaniou E, Varvarigou AD, Archimandritis SC.
    Bioconjug Chem; 2009 May 20; 20(5):856-67. PubMed ID: 19344122
    [Abstract] [Full Text] [Related]

  • 15. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
    Zhang X, Cai W, Cao F, Schreibmann E, Wu Y, Wu JC, Xing L, Chen X.
    J Nucl Med; 2006 Mar 20; 47(3):492-501. PubMed ID: 16513619
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.
    Ait-Mohand S, Fournier P, Dumulon-Perreault V, Kiefer GE, Jurek P, Ferreira CL, Bénard F, Guérin B.
    Bioconjug Chem; 2011 Aug 17; 22(8):1729-35. PubMed ID: 21761921
    [Abstract] [Full Text] [Related]

  • 17. 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent.
    Karra SR, Schibli R, Gali H, Katti KV, Hoffman TJ, Higginbotham C, Sieckman GL, Volkert WA.
    Bioconjug Chem; 1999 Aug 17; 10(2):254-60. PubMed ID: 10077475
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.
    Gali H, Hoffman TJ, Sieckman GL, Owen NK, Katti KV, Volkert WA.
    Bioconjug Chem; 2001 Aug 17; 12(3):354-63. PubMed ID: 11353532
    [Abstract] [Full Text] [Related]

  • 19. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.
    Lane SR, Nanda P, Rold TL, Sieckman GL, Figueroa SD, Hoffman TJ, Jurisson SS, Smith CJ.
    Nucl Med Biol; 2010 Oct 17; 37(7):751-61. PubMed ID: 20870150
    [Abstract] [Full Text] [Related]

  • 20. Bombesin analogues for gastrin-releasing peptide receptor imaging.
    Nanda PK, Pandey U, Bottenus BN, Rold TL, Sieckman GL, Szczodroski AF, Hoffman TJ, Smith CJ.
    Nucl Med Biol; 2012 May 17; 39(4):461-71. PubMed ID: 22261143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.